VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs James Hardie Industries plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisJames Hardie Industries plc
JHX · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into James Hardie Industries plc's moat claims, evidence, and risks.
View JHX analysisComparison highlights
- Moat score gap: James Hardie Industries plc leads (74 / 100 vs 71 / 100 for AstraZeneca PLC).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); James Hardie Industries plc has 4 segments (64.2% in Siding & Trim).
- Primary market structure: Oligopoly vs Quasi-Monopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; James Hardie Industries plc has 5 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
James Hardie Industries plc
Siding & Trim
North American fiber cement exterior siding & trim (plus related exterior products)
North America (primarily U.S. and Canada)
Homebuilders, contractors, remodelers, dealers/distributors, and retailers
Manufacturer / branded building-products supplier
64.2%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
James Hardie Industries plc strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
James Hardie Industries plc segments
Full profile >Siding & Trim
Quasi-Monopoly
Deck, Rail & Accessories
Oligopoly
Australia & New Zealand
Oligopoly
Europe
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.